Medigus Signs Agreement With Sinopharm, Distributes in China

Medigus, an endoscopic device company headquartered in Israel, has signed an agreement with Sinopharm, China National Pharmaceutical Group.


Sinopharm has agreed to purchase and distribute at least $3.85 million of the company's SRS II Systems.

SRS II Systems are designed to be used as a minimally invasive treatment for Gastroesophageal Reflux Disease.

More Articles on Gastroenterology:
Dr. Nanda Kerkar Joins Children's Hospital LA
Study Shows Accuracy of Optical Biopsy Over Traditional Endoscopy
First Alabama Pediatric Colorectal Clinic Opens




Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast